Cytokine-release syndrome: general risk-factor modification--preparation of high-risk patients for use of OKT3.
Radhakrishnan
J
J
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.
Cohen
D J
DJ
D002493:Central Nervous System Diseases / Q000209:etiology* / Q000276:immunology; D016207:Cytokines / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D013577:Syndrome; D013601:T-Lymphocytes / Q000276:immunology
D016207:Cytokines; D016853:Muromonab-CD3